Aehr Test Systems Misses Earnings, Yet Stock Hits All-Time High

Aehr Test Systems (AEHR), ranking by market capitalization, reported its fiscal 2026 Q3 earnings on April 8th, 2026. The company revealed a significant contraction in revenue alongside a sharp deterioration in profitability compared to the prior year period.

While the reported revenue of $10.31 million missed analyst expectations due to a 43.7% year-over-year decline, the company's forward-looking guidance remained robust, projecting a return to non-GAAP profitability in the fourth quarter of 2026. This optimistic outlook, coupled with record bookings, suggests the market is pricing in future growth potential despite the current quarterly miss.

Revenue

Total revenue for the third quarter of 2026 fell to $10.31 million, representing a substantial 43.7% decrease from the $18.31 million recorded in the same period of 2025. This decline reflects a temporary slowdown in immediate sales volume, though the company continues to secure significant future commitments.

Earnings/Net Income

Aehr Test Systems saw its financial losses deepen significantly in Q3 2026, with net loss per share widening to -$0.10 from a loss of -$0.02 in the previous year, marking a 400% increase in the loss per share. Concurrently, the company's total net loss expanded to -$3.20 million, a 398.1% surge from the -$643,000 loss reported in Q3 2025. The EPS performance was poor, reflecting a substantial deterioration in profitability metrics compared to the prior year.

Price Action

The stock price of Aehr Test SystemsAEHR-- has demonstrated remarkable volatility and strength, jumping 10.13% on the latest trading day and surging 70.33% over the most recent full trading week. Additionally, the stock has climbed 77.37% month-to-date, reaching an all-time high of $66.28 before settling at $63.16, a session gain of 25.69%.

Post-Earnings Price Action Review

The strategy of buying AehrAEHR-- Test Systems (AEHR) shares on the date of its revenue raise announcement and holding for 30 days showed favorable performance. The cumulative return was 21.78%, with a 17.95% gain in the holding period and an additional 3.83% during the next 30 days. This suggests a strong short-term reaction to the earnings news, with continued positive sentiment supporting further gains in the immediate term.

CEO Commentary

Gayn Erickson, President, CEO, and Director, highlighted strong business performance with $37 million in Q3 bookings and a record $50 million effective backlog, driven by robust demand in AI, silicon photonics, and power semiconductors. He emphasized strategic priorities, including expanding wafer-level burn-in solutions for AI processors and silicon photonics, addressing technical challenges in benchmark evaluations, and scaling manufacturing capacity via a new contract manufacturer. Erickson expressed optimism about long-term growth, stating, "we believe we have a clear path to sustain long-term growth as our installed base expands across AI, silicon photonics, power semiconductors, memory and other high-performance applications." Challenges included delayed orders and technical hurdles in customer evaluations, but he remained confident in Aehr's leadership in both wafer-level and package-level burn-in solutions.

Guidance

Chris Siu, CFO, provided full-year 2026 revenue guidance on the high end of $45 million to $50 million, with non-GAAP net loss per diluted share projected between -$0.13 and -$0.09. The company expects improved gross margins from increased manufacturing activity, a return to non-GAAP profitability in Q4 2026, and second-half 2026 bookings on the high end of $60 million to $80 million. Quantitative targets include $10.3 million in Q3 revenue and $37.2 million in Q3 bookings, with a $50.9 million effective backlog driving visibility for fiscal 2027 growth.

Additional News

Aehr Test Systems recently secured a major win with a new customer for its high-power FOX-XP WLBI system, specifically designed for hyperscale data center optical interconnect markets. This customer is developing advanced silicon photonics-based transceivers to address the accelerating demand for high-speed fiber optic links in AI data centers. Furthermore, the company signed a contract with a major AI client for multiple testing machines for data center use and engaged a large data center customer to test custom AI chips at scale. These strategic acquisitions position Aehr to participate in a significant multiyear expansion of silicon photonics production. While the stock has surged over 200% year-to-date, analysts note that while Aehr offers potential, other AI stocks may present different risk-reward profiles regarding valuation and immediate downside protection in the current market environment.